Amniotic Membrane Market by Product, Application, End User

Description

List of Tables

[193 Pages Report] The Amniotic Membrane Market size was estimated at USD 931.83 million in 2022 and expected to reach USD 1,026.73 million in 2023, at a CAGR 9.37% to reach USD 1,908.60 million by 2030.

Global Amniotic Membrane Market

KEY MARKET STATISTICS
Base Year [2022]	USD 931.83 million
Estimated Year [2023]	USD 1,026.73 million
Forecast Year [2030]	USD 1,908.60 million
CAGR (%)	9.37%

The amniotic membrane market encompasses producing, distributing, and selling amniotic membranes for various medical applications. Amniotic membranes, derived from the innermost layer of the placenta and contain a unique combination of cells and extracellular matrix, have regenerative properties used in various therapeutic practices, especially in ophthalmology, wound care, and surgical procedures. Amniotic membranes are utilized in various medical applications due to their anti-inflammatory, anti-fibrotic, and anti-microbial properties and their ability to support stem cell proliferation. Nonetheless, the growth of the amniotic membrane market faces several limitations and challenging factors, such as ethical constraints, regulation, and cost constraints. Advances in preservation technologies, such as cryopreservation and dehydrated products, are making storing and transporting these membranes easier, thus expanding their availability and shelf-life. Ongoing research is discovering new therapeutic applications for the amniotic membrane, opening up further markets. Increased awareness among healthcare professionals and patients about the benefits of amniotic membrane-based products is also creating opportunities for market expansion.

Regional Insights

The amniotic membrane market in the Americas is experiencing substantial growth, driven by a strong presence of sophisticated healthcare infrastructure, heightened awareness amongst both practitioners and patients, and favorable reimbursement policies. The United States stands out as the primary market due to its well-established healthcare system and the presence of key players in the regenerative medicine sector. In the EMEA region, demand for amniotic membranes is growing, driven by increased adoption in ophthalmology and wound care. The European market is particularly robust, supported by stringent EU regulations that ensure product quality and safety. The rise in chronic diseases and an aging population contribute to this heightened demand. The Middle East exhibits growth potential with increased investments in healthcare infrastructure, though market penetration is still in its nascent stages compared to Europe. In Africa, the market is relatively underdeveloped, faced with challenges such as limited healthcare facilities and lower awareness levels, but it holds potential for future growth due to a gradual improvement in healthcare systems. The APAC region is anticipated to be the fastest-growing market for amniotic membranes, thanks to rapidly advancing healthcare infrastructure, increasing investments in regenerative medicine, and an expansive patient population. Countries like China, Japan, and India are leading this growth trajectory.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Amniotic Membrane Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Amniotic Membrane Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Amniotic Membrane Market, highlighting leading vendors and their innovative profiles. These include Applied Biologics, LLC, BioStem Technologies, Inc., BioTissue Holdings, Inc., Celularity Inc., FzioMed Inc., Genesis Biologics Inc., Integra LifeSciences Holdings Corporation, Katena Products, Inc., Laboratoire CCD, Lucina BioSciences, LLC, Merakris Therapeutics, MiMedx Group, Inc., Next Biosciences (Pty) Limited, NuVision Biotherapies Ltd, Organogenesis Holdings Inc., PuraGraft, Seed Biotech, Inc., Skye Biologics Holdings, LLC, Smith & Nephew PLC, Stryker Corporation, Surgenex, LLC, Surgilogix, The Electrospinning Company, Thea Pharma Inc., Ventris Medical, LLC, and VIVEX Biologics, Inc..

Market Segmentation & Coverage

This research report categorizes the Amniotic Membrane Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Cryopreserved Amniotic Membrane
- Lyophilization Amniotic Membrane
Application
- Ophthalmology
- Surgical Wound
End User
- Ambulatory Surgical Center
- Hospital
- Research Centers Laboratory
- Specialized Clinic
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Amniotic Membrane Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Amniotic Membrane Market?

3. What are the technology trends and regulatory frameworks in the Amniotic Membrane Market?

4. What is the market share of the leading vendors in the Amniotic Membrane Market?

5. Which modes and strategic moves are suitable for entering the Amniotic Membrane Market?

Product Code: MRR-036CEF50859C

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Amniotic Membrane Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Demand for amniotic membrane transplantations
  - 5.1.1.2. Rising the geriatric population around the world
  - 5.1.1.3. Growing incidence of accident and trauma cases
- 5.1.2. Restraints
  - 5.1.2.1. Lack of skilled professionals in healthcare sector
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing R&D activities in the amniotic membrane for regenerative medicine and stem cell biology
  - 5.1.3.2. Growing awareness of amniotic membrane benefits and birth tissue donations
- 5.1.4. Challenges
  - 5.1.4.1. Maintaining sufficient storage temperature level
5.2. Market Segmentation Analysis
- 5.2.1. Product: Increase in use of cryopreserved amniotic membranes live cell therapy
- 5.2.2. Application: Employment of amniotic membrane in ophthalmology treating complex ocular surface diseases
- 5.2.3. End User: Significant use products across Hospitals for surgical procedures
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter's Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Amniotic Membrane Market, by Product

6.1. Introduction
6.2. Cryopreserved Amniotic Membrane
6.3. Lyophilization Amniotic Membrane

7. Amniotic Membrane Market, by Application

7.1. Introduction
7.2. Ophthalmology
7.3. Surgical Wound

8. Amniotic Membrane Market, by End User

8.1. Introduction
8.2. Ambulatory Surgical Center
8.3. Hospital
8.4. Research Centers Laboratory
8.5. Specialized Clinic

9. Americas Amniotic Membrane Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Amniotic Membrane Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Amniotic Membrane Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Merger & Acquisition
  - 12.3.1.1. Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations
- 12.3.2. Agreement, Collaboration, & Partnership
  - 12.3.2.1. NovaBay to commercialize Amniotic Tissue Allograft as Avenova Allograft

13. Competitive Portfolio

13.1. Key Company Profiles
- 13.1.1. Applied Biologics, LLC
- 13.1.2. BioStem Technologies, Inc.
- 13.1.3. BioTissue Holdings, Inc.
- 13.1.4. Celularity Inc.
- 13.1.5. FzioMed Inc.
- 13.1.6. Genesis Biologics Inc.
- 13.1.7. Integra LifeSciences Holdings Corporation
- 13.1.8. Katena Products, Inc.
- 13.1.9. Laboratoire CCD
- 13.1.10. Lucina BioSciences, LLC
- 13.1.11. Merakris Therapeutics
- 13.1.12. MiMedx Group, Inc.
- 13.1.13. Next Biosciences (Pty) Limited
- 13.1.14. NuVision Biotherapies Ltd
- 13.1.15. Organogenesis Holdings Inc.
- 13.1.16. PuraGraft
- 13.1.17. Seed Biotech, Inc.
- 13.1.18. Skye Biologics Holdings, LLC
- 13.1.19. Smith & Nephew PLC
- 13.1.20. Stryker Corporation
- 13.1.21. Surgenex, LLC
- 13.1.22. Surgilogix
- 13.1.23. The Electrospinning Company
- 13.1.24. Thea Pharma Inc.
- 13.1.25. Ventris Medical, LLC
- 13.1.26. VIVEX Biologics, Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing